D. E. Shaw & Co., Inc. Danaher Corp Put Options Transaction History

D. E. Shaw & Co., Inc.

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$239.25 - $280.76 $2.42 Million - $2.84 Million	10,100 New	10,100 $2.81 Million
Q1 2023 May 15, 2023	SELL	$239.75 - $277.0 $2.01 Million - $2.33 Million	-8,400 Reduced 16.8%	41,600 $10.5 Million
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $8.67 Million - $10.1 Million	35,900 Added 254.61%	50,000 $13.3 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $444,708 - $2.71 Million	1,800 Added 14.63%	14,100 $3.64 Million
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $4.2 Million - $5.3 Million	-17,700 Reduced 59.0%	12,300 $3.12 Million
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $2.57 Million - $3.16 Million	10,000 Added 50.0%	30,000 $8.8 Million
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $2.72 Million - $3.32 Million	10,000 Added 100.0%	20,000 $6.09 Million
Q4 2020 Feb 16, 2021	SELL	$212.5 - $245.46 $318,750 - $368,190	-1,500 Reduced 13.04%	10,000 $2.22 Million
Q3 2020 Nov 16, 2020	BUY	$177.16 - $215.33 $265,740 - $322,995	1,500 Added 15.0%	11,500 $2.48 Million
Q1 2020 May 15, 2020	BUY	$121.39 - $169.05 $1.21 Million - $1.69 Million	10,000 New	10,000 $1.38 Million

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.